Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

Por Galli, L, Fontana, A, Galli, C, Landi, L, Fontana, E, Antonuzzo, A, Andreuccetti, M, Aitini, E, Barbieri, R, Di Marsico, R, Falcone, A
Publicado em 2007

First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II...

Por Tibaldi, C, Vasile, E, Antonuzzo, A, Di Marsico, R, Fabbri, A, Innocenti, F, Tartarelli, G, Amoroso, D, Andreuccetti, M, Dico, M Lo, Falcone, A
Publicado em 2008

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer

Por Vasile, E, Masi, G, Fornaro, L, Cupini, S, Loupakis, F, Bursi, S, Petrini, I, Di Donato, S, Brunetti, I M, Ricci, S, Antonuzzo, A, Chiara, S, Amoroso, D, Andreuccetti, M, Falcone, A
Publicado em 2009